BioNexus Gene Lab Price to Book Ratio 2019-2025 | BGLC
Historical price to book ratio values for BioNexus Gene Lab (BGLC) over the last 10 years. The current price to book ratio for BioNexus Gene Lab as of June 13, 2025 is 0.64.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
BioNexus Gene Lab Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-06-13 | 2.76 | 6.39 | |
2025-03-31 | 2.36 | $0.43 | 5.46 |
2024-12-31 | 2.80 | $0.46 | 6.04 |
2024-09-30 | 4.45 | $5.23 | 0.85 |
2024-06-30 | 4.75 | $5.40 | 0.88 |
2024-03-31 | 7.06 | $5.29 | 1.33 |
2023-12-31 | 5.30 | $0.55 | 9.70 |
2023-09-30 | 8.70 | $5.44 | 1.60 |
2023-06-30 | 26.52 | $0.34 | 77.25 |
2023-03-31 | 64.80 | $4.53 | 14.30 |
2022-12-31 | 114.00 | $4.60 | 24.76 |
2022-09-30 | 127.20 | $4.44 | 28.65 |
2022-06-30 | 136.80 | $4.71 | 29.02 |
2022-03-31 | 205.20 | $5.00 | 41.06 |
2021-12-31 | 255.60 | $5.03 | 50.77 |
2021-09-30 | 141.60 | $4.94 | 28.64 |
2021-06-30 | 138.00 | $4.78 | 28.89 |
2021-03-31 | 252.00 | $4.76 | 52.91 |
2020-12-31 | 0.00 | $4.67 | 0.00 |
2020-09-30 | 0.00 | $1.09 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.005B | $0.010B |
BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $143.613B | 26.94 |
Elevance Health (ELV) | United States | $86.883B | 11.21 |
CVS Health (CVS) | United States | $85.338B | 10.61 |
Cencora (COR) | United States | $57.283B | 19.93 |
DiDi Global (DIDIY) | China | $22.826B | 24.25 |
Natera (NTRA) | United States | $22.577B | 0.00 |
Labcorp Holdings (LH) | United States | $21.856B | 17.73 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.669B | 0.00 |
Solventum (SOLV) | United States | $12.768B | 13.52 |
ICON (ICLR) | Ireland | $11.763B | 10.94 |
CochLear (CHEOY) | Australia | $11.550B | 0.00 |
Revvity (RVTY) | United States | $11.024B | 18.97 |
Doximity (DOCS) | United States | $10.503B | 48.63 |
Viatris (VTRS) | United States | $10.469B | 3.60 |
HealthEquity (HQY) | United States | $9.059B | 39.68 |
Avantor (AVTR) | United States | $8.906B | 12.94 |
Medpace Holdings (MEDP) | United States | $8.572B | 22.77 |
Sonic Healthcare (SKHHY) | Australia | $8.393B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.340B | 14.38 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.361B | 25.69 |
BrightSpring Health Services (BTSG) | United States | $3.724B | 34.16 |
Sotera Health (SHC) | United States | $3.244B | 18.43 |
Alignment Healthcare (ALHC) | United States | $2.956B | 0.00 |
Surgery Partners (SGRY) | United States | $2.914B | 37.90 |
Concentras Parent (CON) | United States | $2.749B | 15.89 |
Organon (OGN) | United States | $2.610B | 2.77 |
Ardent Health (ARDT) | United States | $1.881B | 8.02 |
Premier (PINC) | United States | $1.858B | 14.11 |
GeneDx Holdings (WGS) | United States | $1.842B | 70.96 |
Progyny (PGNY) | United States | $1.803B | 39.68 |
PACS (PACS) | United States | $1.573B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.561B | 31.21 |
Teladoc Health (TDOC) | United States | $1.203B | 0.00 |
Pediatrix Medical (MD) | United States | $1.203B | 9.15 |
Establishment Labs Holdings (ESTA) | $1.083B | 0.00 | |
CareDx (CDNA) | United States | $1.035B | 16.17 |
Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
Agilon Health (AGL) | United States | $0.890B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.826B | 7.73 |
QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
Nutex Health (NUTX) | United States | $0.679B | 10.28 |
LifeMD (LFMD) | United States | $0.566B | 0.00 |
Embecta (EMBC) | United States | $0.559B | 3.76 |
Enhabit (EHAB) | United States | $0.495B | 40.75 |
InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
SBC Medicals (SBC) | United States | $0.459B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.453B | 0.00 |
Omada Health (OMDA) | $0.440B | 0.00 | |
COMPASS Pathways (CMPS) | United Kingdom | $0.411B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.255B | 0.00 |
Oncology Institute (TOI) | United States | $0.220B | 0.00 |
Beauty Health (SKIN) | United States | $0.193B | 0.00 |
KindlyMD (KDLY) | United States | $0.150B | 0.00 |
DocGo (DCGO) | United States | $0.148B | 24.17 |
Pheton Holdings (PTHL) | China | $0.114B | 0.00 |
So-Young (SY) | China | $0.097B | 0.00 |
KindlyMD (NAKA) | United States | $0.083B | 0.00 |
OncoCyte (OCX) | United States | $0.076B | 0.00 |
Sera Prognostics (SERA) | United States | $0.064B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.064B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
Biodesix (BDSX) | United States | $0.042B | 0.00 |
ModivCare (MODV) | United States | $0.042B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
INVO Fertility (IVF) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |